how to know when to increase glp 1 dose Administration and dosing schedule of GLP1 receptor agonists and dual How Long Until People Increase

Underlying pattern loss is stable or being managed

A statistically significant decrease was observed only in Sequence 2 (i.e., GSH-C4-first), from baseline to the intermediate visit (p = 0.002)

Day 7 Breakfast (357 calories) 1 cup low-fat plain strained Greek-style yogurt 2 Tbsp

GLP-1 receptor agonists have become a cornerstone of type 2 diabetes management because of their ability to improve glycemic control while promoting weight loss and reducing cardiovascular risk in appropriate patient populations. Foundayo is a once-daily, non-peptide oral GLP-1 receptor agonist that can be taken without food or water restrictions. The convenience of oral administration could expand access to GLP-1 therapy and potentially encourage earlier use in primary care settings. The ACHIEVE-3 findings are particularly notable because they provide the first direct phase 3 comparison between two oral GLP-1 therapies